{
    "root": "541cb475-4dbe-4348-a96b-593cd957a183",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "DOTAREM",
    "value": "20250312",
    "ingredients": [
        {
            "name": "gadoterate meglumine",
            "code": "L0ND3981AG"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "dotarem gadolinium-based contrast agent indicated intravenous magnetic resonance imaging ( mri ) brain ( intracranial ) , spine associated tissues adult pediatric patients ( including term neonates ) detect visualize areas disruption blood brain barrier ( bbb ) and/or abnormal vascularity .",
    "contraindications": "adult pediatric patients : recommended dose dotarem 0.2 ml/kg ( 0.1 mmol/kg ) body weight administered intravenous bolus injection flow rate approximately 2 ml/second adults 1 - 2 ml/second pediatric patients ( including term neonates ) . dose delivered manual power injection .",
    "warningsAndPrecautions": "dotarem injection clear , colorless yellow solution containing 0.5 mmol/ml gadoterate meglumine . dotarem injection pharmacy bulk package supplied 100 ml vials containing 100 ml solution . pharmacy bulk package vial closed rubber stopper sealed aluminum cap contents sterile . dotarem pharmacy bulk package packaged shrink wrapped package 6 , following configurations : 100 ml glass vial ( ndc 67684-2000-4 ) dotarem pharmacy bulk package also packaged box 6 , following configurations : 100 ml glass vial ( ndc 67684-2001-4 ) storage store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp , controlled room temperature ( crt ) ] . solidification occur vial exposure cold , bring dotarem room temperature . allowed stand room temperature minimum 90 minutes , dotarem return clear , colorless yellow solution . , examine product assure solids dissolved container closure damaged . discard vial solids persist .",
    "adverseReactions": "history clinically important hypersensitivity dotarem [ ( 5.2 ) ] .",
    "indications_original": "DOTAREM is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.",
    "contraindications_original": "Adult and pediatric patients: The recommended dose of DOTAREM is 0.2 mL/kg (0.1 mmol/kg) body weight administered as an intravenous bolus injection at a flow rate of approximately 2 mL/second for adults and 1 - 2 mL/second for pediatric patients (including term neonates). The dose is delivered by manual or power injection.",
    "warningsAndPrecautions_original": "DOTAREM Injection is a clear, colorless to yellow solution containing 0.5 mmol/mL of gadoterate meglumine.\n                  \n                  \n                     DOTAREM Injection Pharmacy Bulk Package is supplied in 100 mL vials containing 100 mL of solution.\n                  \n                  Each Pharmacy Bulk Package vial is closed with a rubber stopper and sealed with an aluminum cap and the contents are sterile. DOTAREM Pharmacy Bulk Package is packaged in a shrink wrapped package of 6, in the following configurations:\n                  \n                  100 mL in glass vial (NDC 67684-2000-4)\n                  DOTAREM Pharmacy Bulk Package is also packaged in a box of 6, in the following configurations:\n                  \n                  100 mL in glass vial (NDC 67684-2001-4)\n                  \n                     Storage\n                  \n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP, Controlled Room Temperature (CRT)].\n                  Should solidification occur in the vial because of exposure to the cold, bring DOTAREM to room temperature before use. If allowed to stand at room temperature for a minimum of 90 minutes, DOTAREM should return to a clear, colorless to yellow solution. Before use, examine the product to assure that all solids are dissolved and that the container and closure have not been damaged. Discard the vial if solids persist.",
    "adverseReactions_original": "History of clinically important hypersensitivity reactions to DOTAREM [see Warnings and Precautions (5.2)]."
}